Biomarker implications of gene editing in hematologic diseases: latest updates from ASH 2025
{{output}}
The 2025 American Society of Hematology (ASH) Annual Meeting highlighted rapid advances in gene editing for hematologic diseases, with increasing emphasis on precision editing and early exploration of in vivo delivery strategies. Beyond technological developme... ...
